Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

Quantitative volumetric assessment of pulmonary involvement in patients with systemic sclerosis (SSc).

lung diagnosis

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 17 April 2016 - 09:27 AM

Quantitative volumetric assessment of pulmonary involvement in patients with systemic sclerosis (SSc).

 

The percentage of lower lobe volume (PLLV) of the right lung may decrease in SSc patients with interstitial lung disease and the PLLV may be a quantitative parameter indicating damage in the lung. Quantitative Imaging in Medicine and Surgery, 03/09/2016. (Also see Diagnosis of Scleroderma Pulmonary Involvement)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)